7Baggers
 BioMarin Pharmaceutical Inc. (BMRN) Hits Its 52-Week Low  Yahoo Finance Thu, 02 Oct 2025 00:08:00 GMT
 Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock  Yahoo Finance Wed, 01 Oct 2025 13:45:02 GMT
 u.s. porphyria treatment market set to witness massive growth  openPR.com Wed, 01 Oct 2025 07:25:27 GMT
 The Best Biotech Stocks to Buy  Morningstar Mon, 29 Sep 2025 07:00:00 GMT
 biomarin pharmaceutical hits new 52-week low at $52.48  Markets Mojo Sun, 28 Sep 2025 05:14:19 GMT
 biomarin pharmaceutical hits new 52-week low at $52.48  Markets Mojo Fri, 26 Sep 2025 18:06:36 GMT
 biomarin pharmaceutical stock hits 52-week low at $52.93 by investing.com  Investing.com Nigeria Wed, 24 Sep 2025 10:10:13 GMT
 Biomarin Pharmaceutical stock hits 52-week low at $52.93  Investing.com Tue, 23 Sep 2025 07:00:00 GMT
 biomarin pharmaceutical inc. (nasdaq:bmrn) short interest update  MarketBeat Tue, 23 Sep 2025 05:20:38 GMT
 biomarin pharmaceutical inc. (nasdaq:bmrn) short interest update  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 strs ohio buys shares of 16,000 biomarin pharmaceutical inc. $bmrn  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 strs ohio takes position in biomarin pharmaceutical inc. $bmrn  MarketBeat Fri, 19 Sep 2025 07:11:26 GMT
 north america hurler syndrome treatment market gains with  openPR.com Wed, 17 Sep 2025 10:28:24 GMT
 BMO Capital Reiterates a Buy on BioMarin Pharmaceutical (BMRN)  Yahoo Finance Wed, 17 Sep 2025 07:00:00 GMT
 BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory  Yahoo Tue, 16 Sep 2025 16:37:13 GMT
 new study results highlight biomarin’s voxzogo efficacy in children  Yahoo Finance Tue, 16 Sep 2025 07:00:00 GMT
 user  FinancialContent Tue, 16 Sep 2025 03:31:00 GMT
 here's why biomarin pharmaceutical (bmrn) is a strong growth stock  sharewise.com Tue, 16 Sep 2025 03:18:33 GMT
 published on: 2025-09-15 20:38:06  khodrobank.com Mon, 15 Sep 2025 17:11:51 GMT
 here's why biomarin pharmaceutical (bmrn) is a strong growth stock  Yahoo Finance Mon, 15 Sep 2025 07:00:00 GMT
 aquestive, veeva, oklo, biomarin, tko: trending by analysts  TipRanks Sat, 13 Sep 2025 09:14:39 GMT
 inside the commercial growing pains of hemophilia gene therapies  Fierce Pharma Fri, 12 Sep 2025 07:00:00 GMT
 hemophilia market surges as gene therapy and novel biologics  openPR.com Tue, 09 Sep 2025 07:20:24 GMT
 Biomarin at Morgan Stanley Conference: Strategic Growth and Innovation  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 narrow-moat biomarin supported by voxzogo and rare-disease pipeline  Morningstar Tue, 09 Sep 2025 07:00:00 GMT
 biomarin announces new data from 14 studies at asbmr  TipRanks Mon, 08 Sep 2025 13:10:28 GMT
 inside pharma’s race to deliver new treatments for dwarfism  PharmaVoice Mon, 08 Sep 2025 12:35:17 GMT
 can drug developers help kids with dwarfism reach new heights?  PharmaVoice Mon, 08 Sep 2025 12:35:17 GMT
 why biomarin pharmaceutical (bmrn) stock is down today  Yahoo Finance Mon, 08 Sep 2025 07:00:00 GMT
 biomarin announces phase 3 data for palynziq  TipRanks Sun, 07 Sep 2025 16:32:01 GMT
 biomarin’s pku drug shows nearly 50% blood phe reduction in teens  Investing.com Sat, 06 Sep 2025 07:00:00 GMT
 BioMarin at Wells Fargo Conference: Strategic Focus on Rare Diseases  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 2 safe-and-steady stocks to keep an eye on and 1 facing challenges  Yahoo Finance Wed, 03 Sep 2025 08:59:35 GMT
 biomarin (bmrn) down 4.6% since last earnings report: can it rebound?  Yahoo Finance Wed, 03 Sep 2025 07:00:00 GMT
 biomarin initiated with an outperform at raymond james  TipRanks Tue, 02 Sep 2025 20:36:57 GMT
 Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock  Yahoo Finance Mon, 01 Sep 2025 07:00:00 GMT

BioMarin Pharmaceutical Inc
(NASDAQ:BMRN) 

BMRN stock logo

BioMarin Pharmaceutical Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme to treat mucopolysaccharidosis I, a genetic disease; Brineura for the treatment o...

Founded: 1997
Full Time Employees: 3,001
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends